Astoriom has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom’s footprint in North America, strengthening its presence in high-growth regions for biopharmaceutical, biotechnology and medical technology innovation.
With increased capacity, broader geographic coverage and faster access to GxP stability storage, Astoriom’s global customers will gain local access to reliable and compliant solutions to advance scientific discovery and product innovation.
Precision Stability Storage sites in Wilson (North Carolina), Fort Lauderdale (Florida), and Hopedale (Massachusetts) add to Astoriom’s extensive portfolio of global sample storage facilities, strengthening its current capabilities to address the growing need for comprehensive, cost-effective and scalable solutions. The state-of-the-art facilities provide the highest standards of offsite stability storage, quality and compliance for products that require ICH-specified environmental conditions and storage of temperature-sensitive biological materials. This includes long-term and intermediate conditions (25°C/40% relative humidity (RH), 25°C/60%RH, 30°C/65%RH, 30°C/75%RH, 30°C/35%RH), accelerated storage (40°C/<25%RH, 40°C/75%RH), refrigerated and freezer storage conditions (2–8°C, -20°C, -80°C, -196°C) as well as ambient storage conditions (15–30°C).
Visit Astoriom for more information
